再看甲磺酸伊马替尼。 - Suppr

Suppr

超能文献

Another look at imatinib mesylate.

作者信息

Strebhardt Klaus, Ullrich Axel

机构信息

Department of Obstetrics and Gynecology, School of Medicine, J.W. Goethe University, Frankfurt, Germany.

出版信息

N Engl J Med. 2006 Dec 7;355(23):2481-2. doi: 10.1056/NEJMcibr065325.

DOI:10.1056/NEJMcibr065325

PMID:17151370

Abstract

摘要

相似文献

Another look at imatinib mesylate.

N Engl J Med. 2006 Dec 7;355(23):2481-2. doi: 10.1056/NEJMcibr065325.

Cardiotoxicity of the cancer therapeutic agent imatinib mesylate.

Nat Med. 2006 Aug;12(8):908-16. doi: 10.1038/nm1446. Epub 2006 Jul 23.

J Coll Physicians Surg Pak. 2008 Mar;18(3):176-8.

Imatinib mesylate induced skin hypopigmentation.

J Assoc Physicians India. 2007 Jul;55:527.

In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate'.

Nat Med. 2007 Jan;13(1):15; author reply 15-6. doi: 10.1038/nm0107-15a.

In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate'.

Nat Med. 2007 Jan;13(1):14; author reply 15-6. doi: 10.1038/nm0107-14.

In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate'.

Nat Med. 2007 Jan;13(1):13; author reply 15-6. doi: 10.1038/nm0107-13a.

In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate'.

Nat Med. 2007 Jan;13(1):13-4; author reply 15-6. doi: 10.1038/nm0107-13b.

[Imatinib and solid tumours].

Bull Cancer. 2008 Jan;95(1):99-106. doi: 10.1684/bdc.2008.0557.

[Molecular targeted treatment--new treatment strategy for patients with chronic myeloid leukemia].

Rinsho Byori. 2004 Feb;52(2):136-44.

引用本文的文献

Chemotherapy and cardiotoxicity.

Rev Cardiovasc Med. 2008 Spring;9(2):75-83.

The cancer cell's "power plants" as promising therapeutic targets: an overview.

J Bioenerg Biomembr. 2007 Feb;39(1):1-12. doi: 10.1007/s10863-007-9070-5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Another look at imatinib mesylate.

N Engl J Med. 2006 Dec 7;355(23):2481-2. doi: 10.1056/NEJMcibr065325.

Cardiotoxicity of the cancer therapeutic agent imatinib mesylate.

Nat Med. 2006 Aug;12(8):908-16. doi: 10.1038/nm1446. Epub 2006 Jul 23.

J Coll Physicians Surg Pak. 2008 Mar;18(3):176-8.

Imatinib mesylate induced skin hypopigmentation.

J Assoc Physicians India. 2007 Jul;55:527.

In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate'.

Nat Med. 2007 Jan;13(1):15; author reply 15-6. doi: 10.1038/nm0107-15a.

In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate'.

Nat Med. 2007 Jan;13(1):14; author reply 15-6. doi: 10.1038/nm0107-14.

In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate'.

Nat Med. 2007 Jan;13(1):13; author reply 15-6. doi: 10.1038/nm0107-13a.

In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate'.

Nat Med. 2007 Jan;13(1):13-4; author reply 15-6. doi: 10.1038/nm0107-13b.

[Imatinib and solid tumours].

Bull Cancer. 2008 Jan;95(1):99-106. doi: 10.1684/bdc.2008.0557.

[Molecular targeted treatment--new treatment strategy for patients with chronic myeloid leukemia].

Rinsho Byori. 2004 Feb;52(2):136-44.

引用本文的文献

Chemotherapy and cardiotoxicity.

Rev Cardiovasc Med. 2008 Spring;9(2):75-83.

The cancer cell's "power plants" as promising therapeutic targets: an overview.

J Bioenerg Biomembr. 2007 Feb;39(1):1-12. doi: 10.1007/s10863-007-9070-5.